IRIS
VINCENZI, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 21.833
NA - Nord America 9.219
EU - Europa 4.189
SA - Sud America 1.306
AF - Africa 176
OC - Oceania 60
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 36.786
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 15.103
US - Stati Uniti d'America 8.828
CN - Cina 2.954
HK - Hong Kong 2.108
IT - Italia 2.075
BR - Brasile 947
GB - Regno Unito 632
VN - Vietnam 568
FR - Francia 529
BD - Bangladesh 276
DE - Germania 272
IN - India 233
CA - Canada 210
AR - Argentina 143
NL - Olanda 142
MX - Messico 121
ID - Indonesia 85
ZA - Sudafrica 76
JP - Giappone 75
TR - Turchia 75
FI - Finlandia 66
UA - Ucraina 62
AU - Australia 54
PL - Polonia 52
ES - Italia 48
RU - Federazione Russa 48
IQ - Iraq 45
CO - Colombia 44
SA - Arabia Saudita 44
EC - Ecuador 42
SE - Svezia 34
CL - Cile 31
PY - Paraguay 31
PH - Filippine 30
MD - Moldavia 27
UZ - Uzbekistan 27
CZ - Repubblica Ceca 26
PE - Perù 26
EE - Estonia 25
PK - Pakistan 24
VE - Venezuela 23
AT - Austria 20
CH - Svizzera 20
BE - Belgio 16
MY - Malesia 16
LT - Lituania 15
TW - Taiwan 14
KE - Kenya 13
AZ - Azerbaigian 12
EG - Egitto 12
KR - Corea 12
NP - Nepal 12
TN - Tunisia 12
BH - Bahrain 11
JM - Giamaica 11
TH - Thailandia 11
UY - Uruguay 11
AE - Emirati Arabi Uniti 10
MA - Marocco 10
RO - Romania 10
IL - Israele 9
IR - Iran 9
JO - Giordania 9
PS - Palestinian Territory 9
DZ - Algeria 8
PT - Portogallo 8
SI - Slovenia 8
CR - Costa Rica 7
GT - Guatemala 7
OM - Oman 7
RS - Serbia 7
AL - Albania 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
GR - Grecia 6
HN - Honduras 6
KZ - Kazakistan 6
SY - Repubblica araba siriana 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
IE - Irlanda 5
LB - Libano 5
NI - Nicaragua 5
SN - Senegal 5
BG - Bulgaria 4
BO - Bolivia 4
CI - Costa d'Avorio 4
CY - Cipro 4
DM - Dominica 4
GH - Ghana 4
KW - Kuwait 4
NZ - Nuova Zelanda 4
SV - El Salvador 4
BF - Burkina Faso 3
BY - Bielorussia 3
HU - Ungheria 3
LV - Lettonia 3
ML - Mali 3
SK - Slovacchia (Repubblica Slovacca) 3
TJ - Tagikistan 3
Totale 36.726
Salva come PNG Salva come JPEG
Città #
San Jose 3.132
Hong Kong 2.081
Ashburn 2.037
Singapore 1.959
Rome 1.346
Hefei 1.088
Boardman 659
Beijing 606
London 509
Lauterbourg 473
Dallas 456
Shanghai 361
Ho Chi Minh City 197
Los Angeles 176
New York 152
Council Bluffs 140
Santa Clara 138
Hanoi 125
San Francisco 123
Munich 101
São Paulo 97
Amsterdam 87
Pune 79
Toronto 78
Mexico City 77
Seattle 73
Milan 65
Washington 54
Tokyo 49
Warsaw 48
Johannesburg 42
Frankfurt am Main 41
Turku 40
Chennai 37
Brooklyn 36
Rio de Janeiro 35
Chicago 31
Montreal 30
Las Vegas 26
Melbourne 26
Orem 26
St Louis 26
Stockholm 26
Boston 25
Da Nang 25
Helsinki 25
Naples 23
Tashkent 23
Riyadh 22
Brno 20
Hangzhou 20
Secaucus 20
Biên Hòa 19
Haiphong 19
Phoenix 19
Turin 19
Atlanta 18
Buenos Aires 18
Belo Horizonte 17
Manchester 17
New Delhi 17
Ankara 16
Asunción 16
Charlotte 16
Curitiba 16
Sydney 16
Bologna 15
Buffalo 15
Denver 15
Guangzhou 15
Palermo 15
The Dalles 15
Baghdad 14
Istanbul 14
Bari 13
Jeddah 13
Thái Bình 13
Canberra 12
Central 12
Hasselt 12
Nairobi 12
Porto Alegre 12
Quito 12
West Jordan 12
Brasília 11
Lima 11
Moscow 11
Santiago 11
Florence 10
Medellín 10
Miami 10
Modena 10
Ribeirão Preto 10
Salvador 10
Amman 9
Baku 9
Bogotá 9
Catania 9
Dhaka 9
Fortaleza 9
Totale 17.833
Salva come PNG Salva come JPEG
Nome #
Aspetti etico-clinici del percorso decisionale ed assistenziale per la sedazione palliativa 335
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 300
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 272
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 257
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) 252
A novel predictive biomarker of immunotherapy response in metastatic renal cell carcinoma (mRCC): The lymphocyte microRNA expression profile. 250
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 248
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 246
Doctor-patient communication tricks. Ontological study a Campus Bio-Medico University of Rome 244
96P Induction chemotherapy backbone in frail patients (pts) with advanced NSCLC treated with chemotherapy plus pembrolizumab (P): A single institution retrospective audit of dose intensities from modified regimens 240
Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review 240
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 239
Cardiotossicità da antracicline 236
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 235
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 232
Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials 231
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 229
Sarcopenia Does Not Impact the Outcome of Patients with Multiple Myeloma Consolidated with Autologous Hematopoietic Stem Cell Transplantation 222
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 221
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 221
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 221
Prevention of radiotherapy-induced emesis 217
Premetastatic niche: ready for new therapeutic interventions? 216
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 214
Activity of chemotherapy in inflammatory myofibroblastic tumor (IMT): A retrospective analysis within the Italian Rare Tumours Network (RTR). 213
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 213
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 212
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 211
Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma 211
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 210
Urinary complications from breast cancer metastasis: case report and review of the literature 208
Docetaxel induced pericardial effusion 205
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 204
Survey on learning needs and preferred sources of information to meet these needs in Italian oncology patients receiving chemotherapy 203
A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma 203
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 202
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 200
Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myeloma 199
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 198
A staphylococcus aureus coinfection on a COVID-19 pneumonia in a breast cancer patient 198
CD133 and ABCB5 as stem cell markers on sentinel lymph node from melanoma patients 196
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 194
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 191
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 191
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 177
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 167
A giant sarcoma of the parotid gland: A case report and review of the literature 162
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 154
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 152
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 146
Liver harvesting surgical technique for the treatment of retro-hepatic caval thrombosis concomitant to renal cell carcinoma: perioperative and long-term results in 15 patients without mortality 144
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 139
'Old' and 'new' drugs for the treatment of cancer pain 139
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 138
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 136
Italian translation of the Manchester-Oxford Foot Questionnaire (MOXFQ), with re-assessment of reliability and validity 136
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 136
Circulating endothelial cell (CEC) kinetic in patients with Multiple Myeloma (MM) who receive Au-HSCT (Autologous Hematopoietic Stem Cell Transplantation) 135
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 135
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 134
An international survey on the use of guidelines for palliative sedation therapy 132
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 132
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 131
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 130
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 129
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 126
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 125
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 125
Biological effects of cabozantinib on bone microenvironment 125
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 124
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 123
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 122
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 121
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 121
Cardiotoxicity of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Pathophysiology, Clinical Implications, and Echocardiographic Assessment 119
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 117
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 117
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 116
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 115
Activity of sirolimus in advanced epithelioid hemangioendothelioma (EHE): A retrospective analysis within the Italian Rare Tumor Network (RTR). 115
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 114
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 114
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 114
Adenogenesis Factors FGF7, FGF10, FGF23, IFN-τ and HGF in Endometriosis Tissue Respect to Eutopic Endometrium: An Immunohistochemical Study 113
Azygo-tracheal fistula in a complete implantable central venous system 113
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl) 112
Locally recurrent extraskeletal myxoid chondrosarcoma of the shoulder: a case of complete neoadjuvant radiotherapy response 111
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes 111
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients 111
How I Treat Localized Soft Tissue Sarcomas: Update on Diagnosis, Risk Stratification, and Treatment 110
Idiosyncratic reaction after oxaliplatin infusion 110
Infusion of bevacizumab increases the risk of intestinal perforation: results on a series of 143 patients consecutively treated 110
Persisting perianal ulcer after radiotherapy for anal cancer: recurrence of disease or late radiation-related complication? 110
Atypical chronic head and neck pain: don't forget Eagle's syndrome 110
Activity of sirolimus in patients with progressive epithelioid hemangioendothelioma: A case-series analysis within the Italian Rare Cancer Network 108
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer 104
Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6 104
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma 104
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial 102
Fatal thrombocytopenia and thrombocytopathia: An unusual onset of non small cell lung cancer 100
Totale 16.860
Salva come PNG Salva come JPEG
Categoria #
all - tutte 262.822
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 262.822
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022753 0 9 12 4 49 12 10 9 24 23 26 575
2022/2023194 23 7 3 14 7 8 19 15 15 7 69 7
2023/20241.888 49 213 155 165 156 766 27 113 27 53 81 83
2024/202517.397 277 217 719 138 146 420 296 76 1.521 1.321 5.821 6.445
2025/202616.733 1.506 684 1.068 1.806 640 1.043 4.379 1.462 1.403 1.549 775 418
Totale 36.965